June 10, 2025 – Anna brings more than 20 years of broad experience across the pharmaceutical, medtech, and life science sectors, with a strong track record in general management and leading global teams across strategy, commercial operations, R&D, and organisational development.
She currently serves as COO at Olink Proteomics, where she leads global operations in a high-growth, innovation-driven environment. Her past roles include leading Galderma Nordic AB as Head of the Nordic region, and holding global strategic and marketing leadership positions at Galderma and St. Jude Medical. Her track record spans from product innovation and international expansion to successful commercial execution.
At Inossia, we’re excited to benefit from Anna’s strategic mindset and passion for innovation in health and ageing. Her guidance will be invaluable as we scale our impact in improving quality of life for patients worldwide.
